- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.06. | UI Pharmaceuticals Partners with MimiVax for Glioblastoma Vaccine | ||
| 30.06. | Keystone Folding Box Co., Med-Con Technologies Partner to Enhance Key-Pak | ||
| 30.06. | Piramal Pharma Solutions Breaks Ground on New Expansion | ||
| 30.06. | Veranova Appoints Dr. Matteo Villain as VP of Peptides & Oligonucleotides | ||
| 30.06. | ProFound Therapeutics Inks $70M+ Deal with Novartis | ||
| 30.06. | FDA Approves Takeda's Gammagard Liquid ERC | ||
| 30.06. | Mabion, NovalGen Partner to Bring NVG-222 to Market | ||
| 30.06. | Circio, NeoRegen Biotech to Advance Circular RNA Delivery Collaboration | ||
| 30.06. | Hikma Pharmaceuticals to Invest $1B in U.S. Manufacturing & R&D Capabilities | ||
| 27.06. | Vetter Breaks Ground on Des Plaines Manufacturing Site | ||
| 27.06. | FDA Approves REMS Programs in BMS Cell Therapy Labels | ||
| 27.06. | PrioBio Opens Flagship Cell & Gene Therapy Center of Excellence in Hopewell, NJ | ||
| 26.06. | GenSight Transfers Upstream Phase of LUMEVOQ Manufacturing Process to Catalent | ||
| 26.06. | Incyte Appoints Bill Meury Chief Executive Officer | ||
| 26.06. | AGC Biologics Expands Cell Therapy Development Operations to Asia | ||
| 25.06. | MAIA Biotechnology, Roche Partner for Hard-to-Treat Cancer Therapies | ||
| 25.06. | Silo Pharma, Hoth Therapeutics Enter LOI to Develop Obesity Treatment | ||
| 25.06. | Bio-Thera & SteinCares Ink Dupilumab Biosimilar Deal for Latin America | ||
| 25.06. | Precision BioSciences Gains FDA Rare Pediatric Disease Designation for PBGENE-DMD | ||
| 25.06. | Gilead & Kymera Partner on Novel Cancer Drug | ||
| 24.06. | Phastar Taps Billy Amzal as Head of Strategic Consulting | ||
| 24.06. | Xcell Biosciences, Thermo Fisher Scientific Partner to Advance Cell Therapies | ||
| 24.06. | FDA Approves Benlysta Autoinjector for Kids with Active Lupus Nephritis | ||
| 24.06. | Starton Therapeutics, Bend Partner to Advance STAR-LLD | ||
| 23.06. | Novo Nordisk Axes Relationship with Hims & Hers |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .